AGF U.S. Market Neutral Anti-Beta Fund (BTAL) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $395.2M, listed on AMEX, carrying a beta of -0.88 to the broader market. The fund will invest primarily in long positions in low beta U. public since 2011-09-13.
Snapshot as of May 15, 2026.
- Spot Price
- $12.18
- Total OI
- 204